Henry R. Costantino,Annemarie Stoudt Cohen,Anthony P. Sileno
申请号：
US13314080
公开号：
US20120094903A1
申请日:
2011.12.07
申请国别(地区):
US
年份:
2012
代理人:
摘要：
What is described is a pharmaceutical formulation for intranasal delivery of insulin to a patient, comprising an aqueous mixture of human insulin, a solubilizing agent, a surface active agent, and a thickening agent, wherein said formulation provides a ultra-rapid acting profile to regular human insulin.
